The U.S. Food and Drug Administration requires more time to decide on whether to approve use of Moderna's two-dose COVID-19 vaccine on adolescents 12 to 17 years of age, the pharmaceutical company said.via Chebli Mohamed
The U.S. Food and Drug Administration requires more time to decide on whether to approve use of Moderna's two-dose COVID-19 vaccine on adolescents 12 to 17 years of age, the pharmaceutical company said.
No comments:
Post a Comment
Nigeria News Comments are Moderated.
Clean Comments will be swiftly approved.
No swear words, no racism, allowed